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Primary care management of chronic 
insomnia: a qualitative analysis of the attitudes 
and experiences of Australian general 
practitioners
Jenny Haycock1,2*† , Nicole Grivell1,2† , Anne Redman1,3, Bandana Saini1,4, Andrew Vakulin1,2, Leon Lack1,5, 
Nicole Lovato1,2, Alexander Sweetman1,2, Nicholas Zwar1,6, Nigel Stocks1,7, Oliver Frank1,7, Sutapa Mukherjee1,2,8, 
Robert Adams1,2,8, R. Doug McEvoy1,2 and Elizabeth Hoon1,7† 
Abstract 
Background: Chronic insomnia is a highly prevalent disorder, with ten to thirty percent of Australian adults report-
ing chronic difficulties falling asleep and/or staying asleep such that it causes significant daytime impairment. Current 
Australian general practice guidelines recommend cognitive behavioural therapy for insomnia (CBTi) as first line 
treatment for insomnia, however research suggests that most general practice consultations for insomnia result in a 
prescription for hypnotic or sedative medicines. Although the first point of contact for patients experiencing symp-
toms of insomnia is often general practice, little is known about the current role, experiences and capacity of Austral-
ian general practitioners to manage insomnia. This study aimed to address that gap by exploring the attitudes and 
opinions of general practitioners regarding insomnia management, to inform the development and implementation 
of new models of best practice insomnia care within general practice.
Methods: A descriptive, pragmatic qualitative study. Purposive sampling was used to recruit practising Australian 
general practitioners, varying in age, years of experience and geographic location. Semi-structured interviews were 
conducted, and data analysed using thematic analysis. 
Results: Twenty-eight general practitioners participated in the study. Three major themes were identified: 1) Respon-
sibility for insomnia care; 2) Complexities in managing insomnia; and 3) Navigating treatment pathways. Whilst 
general practitioners readily accepted responsibility for the management of insomnia, provision of care was often 
demanding and difficult within the funding and time constraints of general practice. Patients presenting with comor-
bid mental health conditions and insomnia, and decision-making regarding long-term use of benzodiazepines pre-
sented challenges for general practitioners. Whilst general practitioners confidently provided sleep hygiene education 
to patients, their knowledge and experience of CBTi, and access and understanding of specialised referral pathways 
for insomnia was limited. 
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Background
Chronic insomnia is a common sleep disorder, with 
10–30% of adults in Australia reporting chronic difficul-
ties falling asleep and/or staying asleep, to an extent that 
it causes significant daytime impairment [1–3]. Insom-
nia reduces work performance, social participation and 
health-related quality of life, and increases the risk of 
workplace and motor vehicle accidents [2, 4–6]. Chronic 
insomnia is associated with other chronic health condi-
tions including cardiometabolic diseases [7, 8]. Comor-
bidity also exists between chronic insomnia and mental 
health conditions, most significantly depression and anx-
iety [9, 10]. Chronic insomnia clearly represents a major 
public health issue in Australia, supported by a 2019 
Australian Government parliamentary inquiry which 
acknowledged the considerable impact of insomnia on 
Australian society, and recommended that sleep health 
become a national priority [11]. The serious risks associ-
ated with insomnia make access to effective and afford-
able treatments important.
In Australia, general practitioners (GPs), also known 
as family physicians, are central to primary care [12] 
and commonly provide treatment for sleep disorders. 
Most GPs in Australia work in privately-owned practices 
within a largely publicly funded health care system. GP 
consultations and the cost of most prescribed medica-
tions are subsidised by the Medicare Benefits Schedule 
(MBS) [13] and the Pharmaceutical Benefits Scheme 
(PBS) [14] respectively. In 2019–20, 87% of all GP con-
sultations were provided free at point-of-care without 
any co-payment [15]. Funding streams exist within the 
MBS for the management of chronic diseases and mental 
health conditions [16, 17].
Guidelines published by the Royal Australian College 
of General Practitioners (RACGP) recommend cognitive 
behavioural therapy for insomnia (CBTi) as the first line 
treatment in the management of chronic insomnia, and 
advise that medication use should be limited to the lowest 
dose and the shortest duration possible [18]. Hypnotic or 
sedative medicines for insomnia are associated with high 
rates of adverse effects, and long term use can lead to 
dependence and issues with withdrawal [19–22]. Unlike 
medications, cognitive and behavioural modifications 
such as CBTi address the underlying psychological and 
behavioural factors that maintain insomnia and break 
the cycle of maladaptive learning, resulting in sustained 
improvements [23–26]. Whilst guidelines for insomnia 
management are available to Australian GPs, it is unclear 
if they are being utilised, with recent studies finding that 
Australian GPs rely heavily on sleep hygiene and phar-
macotherapy when consulting with patients with insom-
nia rather than using cognitive behavioural treatments 
[20, 27, 28]. This represents a clear gap between recom-
mended best practice management and current clinical 
care.
Previous research in this area, such as the work by 
Cheung et al. [27] and Sake et al. [28] recognises barriers 
to the integration of CBTi into the primary care setting in 
Australia, including an overreliance on pharmacotherapy, 
often based on perceived patient expectations, and inad-
equate support for non-pharmacological treatment path-
ways. These early studies recruited participants working 
in metropolitan areas in one state of Australia. The inten-
tion of this work was to further develop the knowledge 
in this area by purposely sampling GPs working in met-
ropolitan, rural and remote locations Australia-wide. To 
understand key factors that influence the implementation 
of change we used a conceptual framework developed 
specifically for use in primary care [29].
Recently there has been growing interest in the devel-
opment of new models of care for insomnia management 
in an attempt to improve usage and access to CBTi [30, 
31]. This study was conducted to inform the development 
of new models of insomnia care by exploring the current 
role and experiences of GPs within insomnia assessment 
and management and by identifying barriers and facilita-
tors that influence the provision of best practice insomnia 
care within general practice. This study was conducted as 
part of a larger research program exploring the imple-




This qualitative study employed a pragmatic induc-
tive approach within a larger mixed-methods program 
Conclusions: General practitioners report that whilst assessing and managing insomnia can be demanding, it is 
an integral part of general practice. Insomnia presents complexities for general practitioners. Greater clarity about 
funding options, targeted education about effective insomnia treatments, and referral pathways to specialist services, 
such as benzodiazepine withdrawal support and psychologists, would benefit insomnia management within general 
practice.
Keywords: Insomnia, Sleep, Primary care, General practitioners, General practice, Family practice, Australia, 
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of research exploring the management of insomnia and 
obstructive sleep apnoea (OSA) in primary care. Semi-
structured interviews were conducted and thematic 
analysis guided the data analysis [32]. Informed consent 
was obtained from all participants prior to participation 
in the study. Ethics approval was obtained from the Uni-
versity of Adelaide Human Research Ethics Committee 
(Reference H-2018-257).
Setting
Participants were practising Australian GPs registered 
with the Australian Health Practitioner Regulation 
Agency. Participants practising in metropolitan, rural 
and remote regions of Australia were included as it was 
thought that participant’s experience in insomnia man-
agement could vary with distance from metropolitan 
specialist services.
Recruitment strategy
Purposive sampling was undertaken through two 
recruitment sources, a GP-led closed Facebook group 
GPs Down Under (https:// www. faceb ook. com/ groups/ 
gpsdo wnund er/ about) and professional networks of the 
research team, using advertising that explicitly stated 
that the study was about improving care for patients 
with sleeping issues. This sampling strategy aimed to 
recruit an information-rich sample [33] varied in terms 
of age, level of experience, rurality and state of Aus-
tralia. Recruitment continued until data saturation was 
achieved, whereby new interview data provided few fur-
ther insights (and no new themes) beyond data previ-
ously collected [34].
Data collection
Data were collected between February and August 
2019. A semi-structured interview guide was developed, 
informed by both clinical experience of the researchers 
and a conceptual framework by Lau et al. [29] that iden-
tifies professional, organisational and external factors 
that influence change within primary care. A multi-dis-
ciplinary group of insomnia and OSA specialists, aca-
demic GP clinician/researchers, sleep researchers and 
qualitative experts met to contribute to the development 
of two interview guide drafts, one with fewer and more 
open questions than the other. Iterations continued until 
consensus was reached on the two versions. The guides 
were then piloted with three GPs, which provided insight 
into further refinement and ultimately the development 
of the final interview schedule, which combined the most 
effective parts of both versions, that was used within 
this study. As there were limited changes to the inter-
view guide post-piloting, these data were included in the 
study. Except for one face-to-face interview at the request 
of the participant, all interviews were conducted by tele-
phone by an experienced qualitative researcher (EH) and 
a primary care registered nurse/research assistant (NG). 
Interviews were audio recorded with consent of partici-
pants and transcribed verbatim. Reimbursement ($150 
AUD) for participation was provided, commensurate 
with an accepted hourly rate for GPs.
Data analysis
An inductive thematic analysis was undertaken to ana-
lyse the data [32]. Three researchers (EH, NG and JH) 
familiarised themselves with the data individually and all 
transcripts were checked for accuracy. Data were coded 
independently with NVivo 12 software (QSR Interna-
tional Pty Ltd, Doncaster, Victoria, Australia) using an 
open coding method with each of the researchers devel-
oping initial codes, followed by multiple discussions 
until reaching an agreed coding framework. All three 
researchers identified patterns and relationships in the 
data and developed potential themes through the process 
of thematic analysis [32]. These themes were then dis-
cussed and refined by the three researchers until reach-




A total of 28 GPs participated in the study. Participants 
practised as a GP across the six states of Australia, with 
61% (n = 17) working in a metropolitan area, 32% (n = 9) 
in a rural area and a further 2 participants (7%) in a 
remote location. Years working as a GP varied greatly 
within the group, ranging from 0.3–42  years (median 
6  years). Most participants reported working part time, 
with only four participants (14%) working full-time 
(mean 0.6 [range 0.2–1.0] full-time equivalent). Sixty-
one percent of participants identified as female (n = 17). 
Seventy one percent of participants reported consult-
ing with at least 5 patients with insomnia each month. 
More detailed participant characteristics are presented in 
Table 1.
Following analysis of the data, three major themes were 
identified:
1) Responsibility for insomnia care
2) Complexities in managing insomnia
3) Navigating treatment pathways
Theme 1: responsibility for insomnia care
This theme identified a sense of responsibil-
ity for insomnia management by GPs. Participants 
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consistently recognised that the management of insom-
nia was within the scope of general practice.
For insomnia, I probably don’t see that as a refer-
ral out of general practice very often. Unless there’s 
a very significant mental health component to it. 
(Participant 7)
I can’t remember ever referring someone for insom-
nia. Maybe once I’ve referred someone to a psy-
chologist, but not – generally, no. That’s something 
that to me sits in the scope of general practice. 
(Participant 22)
A number of participants stated that they would initi-
ate referrals to other services as needed, but this was 
most commonly for the management of co-morbid 
insomnia and another condition such as anxiety or 
depression, or for cases of severe, chronic insomnia.
It depends on the severity and depends on if there’s…
a comorb with psychiatric illness then I would prob-
ably be referring on to my psychiatric colleagues. 
(Participant 5)
I think when it gets to that sort of [chronic] level I 
would probably outsource it, so I would probably 
speak to a sleep clinic or a sleep psychologist, if that 
were the case. (Participant 8)
Although the management of care for patients with 
insomnia was considered routine practice by partici-
pants, the time taken to provide the care was not so read-
ily accepted. Many GPs reported concerns about the 
significant demands that insomnia management entailed.
If…someone were to come in for a 10 min appoint-
ment and go through insomnia, that would take 
about 15 to 20 min, and the pressure of running late, 
keeping someone else waiting tends to start playing 
on you at some point down the line. (Participant 10)
Teasing out the things that are contributing to it 
takes a lot of time, and then if you’re wanting to 
change particular behaviours and then doing the 
motivational interviewing to go with that then that 
takes time. (Participant 18)
Participants reported that for most patients, insomnia 
symptoms presented with symptoms of other co-mor-
bid conditions, and that unpacking the issues relating to 
insomnia took time and contributed to longer consulta-
tion times.
In terms of time limitations, it’s often brought up in 
the context of multi-disciplinary comorbid care, so it 
takes a long time to sort these things out and trying 
to disentangle it from all the multiple presentations, 
and patients very rarely present with insomnia as 
their sole issue. (Participant 7)
Funding constraints were identified as limiting more 
comprehensive insomnia management. Many GPs 
reported that the current MBS funding model incentiv-
ised shorter consultation times, resulting in those offer-
ing longer appointments being disadvantaged financially.
You’re kind of taking on a time bomb [providing 
insomnia management], because…if you can put 
through three people every 15  min, you’re going to 
get paid a lot more than those really long extended 
consults. So while it’s rewarding, it’s not financially 
rewarding. That’s the sticking point. (Participant 16)
One participant stated that, although he was interested 
in being more involved in the management of insomnia, 
he was currently unwilling to provide more compre-
hensive care due to the funding limitations associated 
Table 1 Participant characteristics
Participant Rurality Age group Gender Years 
practising as 
a GP
P1 Rural 25–34 Female 3.0
P2 Rural 35–44 Male 4.0
P3 Metropolitan 25–34 Male 5.0
P4 Metropolitan 25–34 Female 2.0
P5 Rural 25–34 Female 3.0
P6 Metropolitan 35–44 Male 1.0
P7 Metropolitan 55–64 Female 29.0
P8 Metropolitan 35–44 Female 6.0
P9 Metropolitan 55–64 Female 26.0
P10 Metropolitan 35–44 Female 6.0
P11 Metropolitan 55–64 Male 35.0
P12 Metropolitan 55–64 Male 42.0
P13 Metropolitan 35–44 Male 10.0
P14 Rural 25–34 Female 5.0
P15 Metropolitan 45–54 Female 20.0
P16 Metropolitan 35–44 Female 17.0
P17 Metropolitan 35–44 Female 0.3
P18 Metropolitan 35–44 Female 3.0
P19 Metropolitan 35–44 Female 14.0
P20 Rural 55–64 Male 30.0
P21 Remote 45–54 Male 20.0
P22 Rural 55–64 Male 30.0
P23 Rural 55–64 Female 30.0
P24 Rural 25–34 Male 4.0
P25 Remote 25–34 Male 5.0
P26 Metropolitan 25–34 Female 5.0
P27 Metropolitan 45–54 Female 26.0
P28 Rural 25–34 Female 2.0
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with the extended time required to provide insomnia 
management.
Unless there was…a stellar rebate for it…I’m not 
doing that on a – on the Medicare, what, 36 bucks or 
whatever they pay us. (Participant 6)
Theme 2: complexities in managing insomnia
This theme highlights the greatest challenges presented 
to GPs’ managing patients with insomnia, namely over-
lapping insomnia and mental health conditions, and the 
management of patients taking benzodiazepines.
Many GPs reported that consultations for the manage-
ment of insomnia were complex. Participants reported 
that care of insomnia was rarely straightforward, with 
patients commonly presenting with insomnia symptoms 
in the presence of another comorbid condition, and that 
the care of insomnia could be demanding.
Often they’re hard…patients [to see] as well, because 
there’s often a lot of other complex issues going on as 
well. It’s not just [that they] can’t sleep. (Participant 
26)
Insomnia was also not always a priority for patients, 
with patients often presenting for care of the other con-
ditions comorbid with insomnia rather than for manage-
ment of the insomnia itself.
It’s normally, “And by the way, I’m having trouble 
sleeping. I’ve come in for this, but by the way…” So 
it tends to be…the bigger of the two issues, but they 
don’t perceive it as that. (Participant 10)
Participants recognised a strong correlation between 
mental health and insomnia. Most commonly, GPs 
related a complex comorbidity between insomnia, 
depression and anxiety. Some GPs reported that at times, 
it was only through an assessment for mental health 
issues that insomnia symptoms were identified.
Some, if they are depressed, part of their screening is 
you ask about their sleep and things, when they are 
anxious…if there is any mental health complaint as 
part of the screening, you could ask about sleep, and 
you realise it’s a lot of that. (Participant 1)
Some participants reported that mental health issues 
and insomnia were often so interrelated that it is neces-
sary to treat them concurrently.
If they keep coming in – if it’s due to an underly-
ing depression, then…you go, “How’s the sleep? And 
how’s your mood?” So it’s very much interrelated. 
You can’t sort of separate it. (Participant 10)
A distinction between insomnia and mental health was 
not always clear, with one participant stating that it may 
be difficult for some GPs to recognise insomnia in the 
midst of mental health symptoms.
A lot of doctors ended up taking, you know, the 
fatigue, the depression, but that’s not the real cause 
of the problem. That’s a consequence of the chronic 
insomnia. (Participant 1)
Of note, one GP considered insomnia not as a condi-
tion in itself, but rather as a symptom of other conditions.
Insomnia isn’t actually a disease. It’s a symptom 
only…insomnia doesn’t happen by itself. (Partici-
pant 11)
Benzodiazepines also presented complexities for GPs. 
Many participants recognised risks associated with long-
term use of benzodiazepines and were reluctant to pre-
scribe benzodiazepines beyond the short term.
I really, really try to avoid it [prescribing benzodi-
azepines]. Just knowing the harm that it can poten-
tially do, and I just feel like it’s quite a Band-Aid. It 
doesn’t solve the issue at hand. It’s not a long-term 
solution. Yes. And I certainly make that very clear 
up front with my patients these days. (Participant 
14)
Some participants, whilst reluctant to prescribe ben-
zodiazepines, acknowledged that there were some situa-
tions in which they were required.
Even though sometimes you can’t find – even if you 
find the reason, you still end up having to use some 
sort of a chemical medication like a benzodiazepine 
sometimes. (Participant 11)
GPs frequently reported that they prescribed benzodi-
azepines in very limited amounts in acute situations or 
for shift-work disorder.
I very, very, very rarely use benzodiazepines. I think 
basically, my use for benzodiazepines would be 
restricted to a grief type scenario…then I might actu-
ally just give them three tablets or something. I’m 
quite a miser with such things. (Participant 8)
With shift work insomnia, I may use a benzodiaz-
epine, and I give them at the start of a – you know, 
when they finish their nightshift, and they’re trying 
to get their sleep/wake cycle back to normal. (Par-
ticipant 21)
Contributing to the GPs’ reluctance to prescribe benzo-
diazepines was an understanding of the problematic con-
sequences of long-term use. Many participants described 
a group of patients that had long-term dependence on 
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benzodiazepines, often ‘inherited’ from other GPs, from 
times when the awareness of risks of benzodiazepines 
was less apparent.
And 20 or 30 years ago the practice of using benzos 
was obviously a lot more prevalent, and so we’ve 
inherited people who have been on their Temazepam 
or their Serepax for 30 years, and you try to get them 
off of it, but it just doesn’t work, because they’re so 
dependent. (Participant 16)
Denying a prescription of benzodiazepines to these 
patients was challenging and many GPs reported difficul-
ties in achieving treatment change with these patients. 
Maintaining rapport with patients, whilst attempting to 
wean them off benzodiazepines, was difficult, particularly 
when the GP was not well known to the patient.
Well, back in the sixties, everyone got that, so every-
one was addicted, and so you have a lot of people in 
their seventies…[that] have been on things like that 
for 20 years, and you are a brave person to try and 
change the direction the wind blows. (Participant 
13)
So I just have to try and establish some trust and 
rapport with them, so that they can trust what I’m 
saying…There has been one doctor that prescribed 
for maybe a long time, and then maybe that doctor 
has retired or they will see someone else for whatever 
reason, and then…suddenly, they find they’ve got 
trouble getting the medication…the patient feels like 
it’s their fault that they’ve become addicted to the 
medication or that they’re seeking it when…in their 
mind, a doctor prescribed it to treat their insomnia, 
so the patients will get a little bit defensive as well. 
(Participant 4)
For some GPs the challenges of supporting long-term 
patients to curtail their use of benzodiazepines was so 
difficult that it had led to a termination of their relation-
ship, with patients instead seeking ongoing prescriptions 
elsewhere.
So if I don’t give them what they want, after my 
22 min in a 15 min booking, they will go to the 6 min 
medicine man around the corner and get what they 
want. (Participant 15)
I just feel like I have to continue, but I will only agree 
to be their doctor – part of the deal is we try and 
wean [benzodiazepines] down. So – have had some 
– you lose a bunch of patients, because of that. (Par-
ticipant 6)
For one GP, the challenge of withdrawing benzodiaz-
epines resulted them being placed in a life-threatening 
situation.
But with benzos, we’ve definitely had…threatened 
violence, threatened use of weapons…losing a litre 
of blood, because they didn’t get the medications 
they’re after. So we’re in a very confronting kind of 
situation. (Participant 27)
The difficulties of managing patients seeking long-term 
benzodiazepine prescriptions resulted in GPs seeking 
alternative care options for their patients. Several partici-
pants stated that they referred patients to psychiatrists 
for review of their benzodiazepine use once they had 
exhausted all approaches available to them.
I referred a few people to the psychiatrists, because 
we’ve had – like they’re wanting long term prescrip-
tion for benzodiazepines, and I felt that I reached 
the end of what I could offer. (Participant 4)
Other participants reported a need for specialist addic-
tion support but identified a lack of appropriate services 
available to assist these patients with benzodiazepine 
withdrawal.
And then for all those troublesome patients who 
are in their 70  s and who are now on two tablets 
of Temazepam and have been for 50  years maybe 
there is somewhere that I can refer them to do this 
in a joint [way] between the specialists and I, and go, 
right, let’s get this down. That would be useful. (Par-
ticipant 10)
If there was a service available to help with benzodi-
azepine, like addiction and withdrawing slowly, that 
would be excellent…even if the patient didn’t want 
to engage with them…If there was a decision-making 
tool that could help with making a withdrawal plan 
that would be excellent. (Participant 4)
Theme 3: navigating treatment pathways
This theme reports the approaches used by GPs when 
providing care for patients with insomnia. It is appar-
ent from this theme that, whilst GPs consistently pro-
vided sleep hygiene, their approach to managing complex 
insomnia was more varied.
The provision of sleep hygiene, that is habits that are 
considered to be conducive to good sleep such a reduc-
ing caffeine intake and regular bedtimes, was commonly 
reported by participants as a strategy used to manage 
insomnia. Almost all of the GPs interviewed expressed 
confidence in providing advice about sleep hygiene with 
most stating that it was their first line of treatment for 
patients presenting with symptoms of insomnia.
Sleep hygiene I recommend to everyone. So I’ve got 
some handouts and stuff for sleep hygiene that I give 
out to people if it’s clear that their sleep hygiene is 
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poor. (Participant 21)
For some GPs offering sleep hygiene education was 
used as a means to avoid prescribing benzodiazepines, 
and for others, a way of supporting patients looking for 
a ‘quick fix’ for their insomnia. One GP reported that this 
‘simple’ education was, at times, all that was needed to 
treat insomnia.
There’s this expectation that you’re going to fix and 
clearly insomnia is not something that you’re going 
to fix today, but having something to give to patients 
as like a takeaway pack of written down instruc-
tions of sleep hygiene, that would be really helpful. 
You would feel like you’ve given them something, and 
it’s almost like a deflector for the requests for benzos. 
(Participant 16)
Sometimes we give advice that, to us, seems ridicu-
lously simple and the patient comes back and says 
they’re totally cured, and it’s all wonderful, and we 
feel we haven’t done much. (Participant 12)
However, many participants acknowledged that insom-
nia management was not always straightforward. The 
approach to managing more complex cases of insomnia 
by GPs varied, as did their knowledge about insomnia 
management strategies and referral pathways. Some GPs 
reported an awareness of cognitive behavioural therapy 
(CBT) as one element of managing insomnia, particu-
larly the use of CBT to target anxiety associated with 
insomnia.
Often there’s an element of anxiety…so you run them 
through mindfulness and a bit of CBT and medita-
tion and that sort of stuff to help them chill out a bit 
and relax. (Participant 25)
Only three participants referred to cognitive behav-
ioural therapy for insomnia (CBTi) within the interview 
and only after the term was introduced by the inter-
viewer, and very few were aware of specific CBT tech-
niques for insomnia. Three GPs reported offering a 
variation of sleep restriction therapy, however there was 
no acknowledgement by those participants of it being a 
component of CBTi.
Sometimes I would do something like sleep restric-
tion with them, getting them to work out how many 
hours of sleep they’re actually getting and then 
delaying bedtime until that and bringing it back 
however many stepwise. (Participant 8)
Some GPs expressed uncertainty about referral options 
for complex cases of insomnia. As reported in Theme 
One, participants referred patients to other health pro-
fessionals when required, but at times they were unsure 
about the referral pathways available to them. Some GPs 
were comfortable referring patients to a psychologist 
or psychiatrist, but others were unsure whether it was 
appropriate to refer a patient to a sleep physician. Rea-
sons for this varied, including a lack of understanding of 
the role that sleep physicians play in insomnia manage-
ment and a belief that insomnia may not be significant 
enough for a referral to a specialist.
Probably consider a sleep physician, but then again, 
I don’t know. It depends what I feel like they might be 
able to offer. (Participant 14)
I wouldn’t necessarily refer someone to a sleep physi-
cian for this. I don’t even know if they – now, that 
I’m talking to you, maybe they do it, maybe they 
don’t. I actually have no idea. (Participant 10)
If I’m not getting anywhere with all of that, I guess, 
referring for specialist in – but I would very, very 
rarely refer to a sleep specialist just for insomnia. 
(Participant 28)
When referral pathways were available, cost was identi-
fied as a barrier to treatment, with one GP reporting that 
it was cheaper for patients to pay for medication than to 
see a psychologist.
I would say that’s probably like less than five per cent 
of my patients would actually go to someone to talk 
about their sleep issues, because of the cost, the cost 
limiting factor. (Participant 15)
It’s much easier to pay $6.90 for Temazepam than 
going to see a psychologist for my sleep. (Participant 
4)
There was also uncertainly expressed about the appro-
priateness of using an MBS funded GP Mental Health 
Treatment Plan (GPMHP) for the management of insom-
nia. Despite distress from sleep issues being an eligible 
condition for a GPMHP [35, 36], insomnia was almost 
never considered by GPs as the primary diagnosis for a 
GPMHP and several participants believed that insomnia 
was not an eligible condition for a GPMHP.
On the mental health plan that I am sending with 
them, the diagnosis is probably not primarily insom-
nia, because that doesn’t fit within the guidelines for 
mental health care plans. (Participant 23)
Of the participants who reported creating a GPMHP in 
the context of insomnia management, almost all consid-
ered insomnia as a secondary condition for the plan, co-
existing with a mental health condition such as anxiety 
and/or depression, that was used as the primary diagno-
sis for the GPMHP.
I’ve referred someone for mental health issues that 
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were contributing to insomnia, but that’s a referral 
not for the insomnia, that’s for the mental health 
condition. (Participant 22)
I think I’ve probably got a lot of patients – well, a 
reasonable number of patients who have insom-
nia who are on a mental health care plan for their 
depression or their anxiety or anything like that, but 
purely – I don’t think I have put them on for insom-
nia. (Participant 24)
Discussion
This qualitative study provides insights into barriers or 
facilitators that could influence the implementation of 
new models of insomnia care within general practice, 
specifically those that had the potential to increase the 
delivery of evidenced-based behavioural treatments as an 
alternative to medications.
The findings of this study indicate a discrepancy 
between current clinical practice and the RACGP clini-
cal guidelines which recommend CBTi as the first line 
treatment for insomnia [18]. GPs rely on sleep hygiene 
education treatment with scarce reference to the other 
components of CBTi, consistent with previous research 
on this topic [37–40]. This is of concern given limited 
evidence about the effectiveness of sleep hygiene as a 
standalone treatment in primary care [41]. Education for 
GPs targeting efficacy of insomnia treatments should be 
considered with the aim of improving uptake of CBTi, the 
most effective treatment.
A finding within this study that has not been explored 
in previous work on this topic is the considerable diffi-
culties experienced by GPs managing patients that they 
have inherited from other GPs who have been prescribed 
benzodiazepines for extended periods of time. Previous 
research indicated that the majority of insomnia patients 
in primary care are managed with pharmacotherapy [20], 
whereas GPs within this study consistently reported that 
they avoid benzodiazepines as the first-line, or long-
term treatment of insomnia. These GPs highlighted spe-
cific challenges involved in managing patients who had 
been taking benzodiazepines for many years: difficulties 
maintaining relationships with patient’s seeking benzo-
diazepine prescriptions, and a lack of accessible support 
services targeting medication withdrawal. It is of note 
that while in this study benzodiazepines were specifi-
cally identified by participants as complex to manage, all 
medications prescribed for insomnia have associated 
challenges, such as side effects and issues of dependency 
[42]. Health professionals not only need education and 
training on benzodiazepine withdrawal, but also require 
increased accessibility of alternative management options 
to drug treatment and medication withdrawal support 
services [43].
This study highlighted that insomnia presentations 
are complex and often overlap with mental health con-
ditions. The Better Access initiative in Australia [17] 
provides access to mental health trained profession-
als through use of a GPMHP, but a novel finding of this 
study was that most GPs did not recognise insomnia as a 
diagnosis appropriate for a GPMHP. Insomnia was some-
times mis-conceptualised as a secondary condition by 
participants despite changes to diagnostic criteria in 2005 
which recommended that ‘comorbid insomnia’ instead 
be used to encourage targeted diagnosis and treatment 
of insomnia per se [5]. This finding again highlights the 
need for education and training for GPs, focussed on 
diagnostic criteria for insomnia and use of GPMHPs for 
chronic insomnia.
Maintaining a clinical relationship with patients, devel-
oping trust and rapport, and managing patient expec-
tations were identified as important in managing this 
complex condition, but also very demanding and time-
consuming within a primary care consultation. This is of 
particular importance given that other studies have iden-
tified that maintaining patient satisfaction and good rela-
tionships with patients can be drivers for GPs prescribing 
benzodiazepines for insomnia [38]. This study also con-
firmed [27] how the current Medicare funding structure 
favouring financial reimbursement to the GP for short, 
timed consultations, makes longer and comprehensive 
treatment for complex conditions such as insomnia, 
challenging. CBTi, the recommended first-line treat-
ment for insomnia is generally administered over weekly 
30–60 min sessions, which may be difficult to achieve in 
primary care. Potential solutions could include improved 
financial incentives for longer consultations, task shift-
ing to practice nurses/practice pharmacists and educa-
tion about the use of GPMHPs for insomnia management 
[16, 17]. More condensed brief behavioural therapy for 
insomnia (BBTi) could also be considered for use in Aus-
tralian general practice [44–46].
In line with other recent research [27, 28], GPs’ man-
agement of insomnia is also influenced by a lack of viable 
referral pathways to specialist care for complex cases. 
Awareness of professional networks is important to pro-
vide the most effective care to patients with complex 
insomnia. For some GPs there are no viable pathways 
because of accessibility issues related to cost and geo-
graphic distance from appropriate services. GPs were 
unsure whether referral to a sleep specialist was appro-
priate for insomnia, possibly reflecting an understand-
ing that sleep specialists are almost exclusively sleep 
apnoea specialists. Local Health Pathways [47] are being 
developed in various Primary Health Networks across 
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Australia, and where these primary care focussed sys-
tems are able to identify accessible local referral path-
ways, they could potentially be useful tools for Australian 
GPs when providing care for people with insomnia.
To improve care for people with insomnia, other 
modalities and treatment options for CBTi should be 
considered. Stepped care models where incremental 
levels (steps) of intervention complexity have proven to 
be effective in the treatment of insomnia [31] and could 
be evaluated in general practice. Many GPs provide 
sleep hygiene education, and this information could be 
upgraded to include self-help CBTi treatments [48]. Sev-
eral online CBTi treatment programs are now available 
and have the potential to be further utilised in general 
practice [49].
This research has provided a broader understanding 
of the context of insomnia management within general 
practice in Australia. Expanding on implementation work 
conducted by Koffel and Hagedorn [50], a recommenda-
tion is that this research be used to inform implementa-
tion of new models of care for insomnia management in 
the primary care setting. The Adelaide-based National 
Centre for Sleep Health Services Research (https:// www. 
ncshsr. com) has drawn on the study’s findings to design 
implementation trials of new technologies and clinical 
pathways to increase GP and patient access to guideline-
recommended CBTi. It will use these and other research 
findings as it endeavours to bring about Australia-wide 
clinical change in the primary care management of 
insomnia [30].
Study strengths and limitations
The use of appropriate research strategies and techniques 
was a key strength of this qualitative study and ensured 
rigour throughout the study design, sample selection, 
data gathering and analysis phases [51]. These strategies 
included purposeful sampling to allow for a maximally 
varied sample, consistent data collection techniques 
until data saturation was reached, and ongoing analysis 
by multiple researchers enabling triangulation. The per-
spectives of participants were emphasised with thick 
description by the inductive approach to data collection 
and analysis [52]. A limitation of this study was that an 
understanding of the term insomnia was not explored 
with participants, with it unclear at times if GPs were 
reflecting on their experiences managing chronic insom-
nia or sleep difficulties more broadly.
Conclusions
It is evident from this study that GPs recognise that the 
management of insomnia is within the scope of gen-
eral practice, but that managing this condition can be 
difficult. Chronic insomnia is often a complex health 
problem, frequently associated with co-morbid men-
tal health conditions and benzodiazepine dependency. 
Whilst this study demonstrates that there are some bar-
riers to change in the management of insomnia in pri-
mary care, there are also many facilitators supporting the 
implementation of new models of care. By harnessing the 
motivation and interest of GPs to be involved in insom-
nia management, there would appear to be some spe-
cific opportunities to improve the provision of care for 
patients presenting with insomnia to the general practice 
setting within Australia. By providing GPs with relevant 
and targeted education and resources, including appro-
priate financial reimbursement through the MBS system 
and support for managing benzodiazepine withdrawal, 
GPs may be empowered to better address the needs of 
the many patients living with chronic insomnia.
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